Skip to main content
. 2017 Jul 31;58(5):1047–1050. doi: 10.3349/ymj.2017.58.5.1047

Table 1. Clinical Characteristics According to the Rhinitis Type.

AR LAR NAR p value* p value
Subjects, n (%) 69 (46.0) 6 (4.0) 75 (50.0)
Age (yr) 28.1±9.5 42.3±20.1 39.5±15.3 0.062 0.878
Male, n (%) 34 (49.3) 3 (50.0) 33 (44.0) 1.000 1.000
Duration (month) 77.6±95.4 106.0±51.2 51.1±82.2 0.125 0.012
M-score§ 14.5±4.4 17.7±6.5 12.1±7.1 0.114 0.058
Comorbidities, n (%)
Asthma 26 (37.7) 1 (16.7) 16 (21.3) 0.410 1.000
Atopic dermititis 14 (20.3) 0 (0) 1 (1.3) 0.586 1.000
Urticaria 4 (5.8) 0 (0) 4 (5.3) 1.000 1.000
Drug allergy 4 (5.8) 1 (16.7) 3 (4.0) 0.349 0.269
Food allergy 4 (5.8) 0 (0) 3 (4.0) 1.000 1.000
Total IgE 551.3±768.4 62.5±75.3 73.2±88.2 0.004 0.914

AR, allergic rhinitis; LAR, local allergic rhinitis; NAR, non-allergic rhinitis; IgE, immunoglobulin E.

Continuous variables are expressed as mean±standard deviation.

*Significant difference between LAR and AR, Significant difference between LAR and NAR, Disease in duration, §Medication score at the first clinic visit.